Literature DB >> 22044428

Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions.

Sudarshana Purkayastha1, Jason Ford, Baishali Kanjilal, Souleymane Diallo, Joseph Del Rosario Inigo, Lorenz Neuwirth, Abdeslem El Idrissi, Zaghloul Ahmed, Andrzej Wieraszko, Efrain C Azmitia, Probal Banerjee.   

Abstract

Aberrant dopamine release in the prefrontal cortex (PFC) is believed to underlie schizophrenia, but the mechanistic pathway through which a widely used antipsychotic, clozapine (Clz), evokes neurotransmitter-releasing electrical stimulation is unclear. We analyzed Clz-evoked regulation of neuronal activity in the PFC by stimulating axons in layers IV and V and recording the electrical effect in the post-synaptic pyramidal cells of layers II and III. We observed a Clz-evoked increase in population spike (PS), which was mediated by serotonin 1A receptor (5-HT(1A)-R), phospholipase Cβ, and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). Immunoblotting demonstrated that the Clz-activation of CaMKII was 5-HT(1A)-R-mediated. Intriguingly, the NMDA receptor (NMDA-R) antagonist (±)2-amino-5-phosphonovaleric acid (APV) eliminated the Clz-mediated increase in PS, suggesting that the 5-HT(1A)-R, NMDA-R and CaMKII form a synergistic triad, which boosts excitatory post-synaptic potential (EPSP), thereby enhancing PS. In corroboration, Clz as well as NMDA augmented field EPSP (fEPSP), and WAY100635 (a 5-HT(1A)-R antagonist), APV, and a CaMKII inhibitor eliminated this increase. As previously shown, CaMKII binds to the NMDA-R 2B (NR2B) subunit to become constitutively active, thereby inducing α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor recruitment to the post-synaptic membrane and an increase in fEPSP. Co-immunoprecipitation demonstrated that Clz potentiates interactions among CaMKII, NR2B, and 5-HT(1A)-R, possibly in the membrane rafts of the post-synaptic density (PSD), because pretreatment with methyl-β-cyclodextrin (MCD), an agent that disrupts rafts, inhibited both co-immunoprecipitation as well as fEPSP. In summary, Clz functions in the PFC by orchestrating a synergism among 5-HT(1A)-R, CaMKII, and NMDA-R, which augments excitability in the PFC neurons of layers II/III.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044428      PMCID: PMC3253201          DOI: 10.1111/j.1471-4159.2011.07565.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  52 in total

Review 1.  Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

Authors:  M J Millan
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

Review 2.  The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

Authors:  R A Bantick; J F Deakin; P M Grasby
Journal:  J Psychopharmacol       Date:  2001-03       Impact factor: 4.153

3.  WAY-100635 has high selectivity for serotonin 5-HT(1A) versus dopamine D(4) receptors.

Authors:  Jean-Claude Martel; Nathalie Leduc; Anne-Marie Ormière; Valérie Faucillon; Nathalie Danty; Charlène Culie; Didier Cussac; Adrian Newman-Tancredi
Journal:  Eur J Pharmacol       Date:  2007-07-13       Impact factor: 4.432

4.  5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.

Authors:  J Ichikawa; H Ishii; S Bonaccorso; W L Fowler; I A O'Laughlin; H Y Meltzer
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

5.  Epileptiform activity and EPSP-spike potentiation induced in rat hippocampal CA1 slices by repeated high-K(+): involvement of ionotropic glutamate receptors and Ca(2+)/calmodulin-dependent protein kinase II.

Authors:  A Semyanov; O Godukhin
Journal:  Neuropharmacology       Date:  2001       Impact factor: 5.250

6.  Intracellular modulation of NMDA receptor function by antipsychotic drugs.

Authors:  J C Leveque; W Macías; A Rajadhyaksha; R R Carlson; A Barczak; S Kang; X M Li; J T Coyle; R L Huganir; S Heckers; C Konradi
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 7.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

8.  Stimulation- and palmitoylation-dependent changes in oligomeric conformation of serotonin 5-HT1A receptors.

Authors:  Fritz Kobe; Ute Renner; Andrew Woehler; Jakub Wlodarczyk; Ekaterina Papusheva; Guobin Bao; Andre Zeug; Diethelm W Richter; Erwin Neher; Evgeni Ponimaskin
Journal:  Biochim Biophys Acta       Date:  2008-03-12

9.  Identification of a serotonin/glutamate receptor complex implicated in psychosis.

Authors:  Javier González-Maeso; Rosalind L Ang; Tony Yuen; Pokman Chan; Noelia V Weisstaub; Juan F López-Giménez; Mingming Zhou; Yuuya Okawa; Luis F Callado; Graeme Milligan; Jay A Gingrich; Marta Filizola; J Javier Meana; Stuart C Sealfon
Journal:  Nature       Date:  2008-02-24       Impact factor: 49.962

10.  Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders.

Authors:  Nobuyuki Yamasaki; Motoko Maekawa; Katsunori Kobayashi; Yasushi Kajii; Jun Maeda; Miho Soma; Keizo Takao; Koichi Tanda; Koji Ohira; Keiko Toyama; Kouji Kanzaki; Kohji Fukunaga; Yusuke Sudo; Hiroshi Ichinose; Masashi Ikeda; Nakao Iwata; Norio Ozaki; Hidenori Suzuki; Makoto Higuchi; Tetsuya Suhara; Shigeki Yuasa; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2008-09-10       Impact factor: 4.041

View more
  15 in total

Review 1.  Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Authors:  Andrea de Bartolomeis; Gianmarco Latte; Carmine Tomasetti; Felice Iasevoli
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

2.  CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4.

Authors:  O M Ogundele; C C Lee
Journal:  Brain Res Bull       Date:  2017-11-11       Impact factor: 4.077

3.  Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.

Authors:  Shigeyuki Yamamoto; Hiroyuki Ohba; Shingo Nishiyama; Norihiro Harada; Takeharu Kakiuchi; Hideo Tsukada; Edward F Domino
Journal:  Neuropsychopharmacology       Date:  2013-07-24       Impact factor: 7.853

Review 4.  Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti
Journal:  Mol Neurobiol       Date:  2012-07-05       Impact factor: 5.590

5.  5-HT2A receptor activation enhances NMDA receptor-mediated glutamate responses through Src kinase in the dendrites of rat jaw-closing motoneurons.

Authors:  Masanori Dantsuji; Shiro Nakamura; Kiyomi Nakayama; Ayako Mochizuki; Sook Kyung Park; Yong Chul Bae; Masahiko Ozeki; Tomio Inoue
Journal:  J Physiol       Date:  2019-04-11       Impact factor: 5.182

Review 6.  Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.

Authors:  A de Bartolomeis; E F Buonaguro; F Iasevoli
Journal:  Psychopharmacology (Berl)       Date:  2012-11-21       Impact factor: 4.530

Review 7.  Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor.

Authors:  Jieon Lee; Diana Avramets; Byungsun Jeon; Hyunah Choo
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

Review 8.  The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.

Authors:  Ralf Brisch; Arthur Saniotis; Rainer Wolf; Hendrik Bielau; Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts; Katharina Braun; Anna Katharina Braun; Zbigniew Jankowski; Jaliya Kumaratilake; Jaliya Kumaritlake; Maciej Henneberg; Tomasz Gos
Journal:  Front Psychiatry       Date:  2014-05-19       Impact factor: 4.157

9.  The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.

Authors:  Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro; Andrea de Bartolomeis
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

10.  The PPM1F gene moderates the association between PTSD and cortical thickness.

Authors:  Danielle R Sullivan; Filomene G Morrison; Erika J Wolf; Mark W Logue; Catherine B Fortier; David H Salat; Jennifer R Fonda; Annjanette Stone; Steven Schichman; William Milberg; Regina McGlinchey; Mark W Miller
Journal:  J Affect Disord       Date:  2019-08-19       Impact factor: 6.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.